Neocate recognises the importance of evidence based practice. Research studies using Neocate have been presented at leading scientific meetings and published in expert peer-reviewed journals. Neocate has over 35 years clinical experience and over 90 publications which support the use of Neocate in a range of medical conditions.
Amino acids do not interact with the immune system and therefore do not lead to an allergic response1.
The hypoallergenicity of Neocate has been established as per the American Academy of Pediatrics (AAP) 1990 recommendations. The AAP recommendations are also endorsed by the European Society of Paediatric Gastroenterology and Nutrition (ESPGHAN) and the European Society of Paediatric Allergy and Clinical Immunology (ESPACI)2.
Using the above criteria, Neocate was tested in infants and children with hypersensitivity to cow's milk. Sampson et al. showed that Neocate is ''hypoallergenic'' and is well tolerated by children who are allergic to cow's milk3.
Neocate is an effective formula for the dietary management of CMA and MFPA in thousands of infants and toddlers in the UK and around the world.
*MIMS, November 2020.
Please ensure your role and areas of interest are up to date.